REPURPOSING DRUGS; MORE THAN $20BILLION IN SALES

A recent Thomson Reuters report indicates that drug repositioning is expected to generate up to $20Billion in annual sales during 2012, thus opening up a new source of revenue to large, medium and small Pharma companies.